Cortical interneuron loss and symptom heterogeneity in Huntington disease

Annals of Neurology

Volumn 75, Issue 5, 2014, Pages 717-727

  Kim, Eric H ^a   Thu, Doris C V ^a,b   Tippett, Lynette J ^a   Oorschot, Dorothy E ^c   Hogg, Virginia M ^a   Roxburgh, Richard ^a,d   Synek, Beth J ^a,d   Waldvogel, Henry J ^a   Faull, Richard L M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b EPFL   (Switzerland)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CALBINDIN 1; CALRETININ; PARVALBUMIN;

ADULT; AGED; ANTERIOR CINGULATE; ARTICLE; BRAIN CELL; BRAIN TISSUE; CAG REPEAT; CELL COUNTING; CELL LOSS; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL INTERNEURON; FEMALE; GENE; HTT GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; INTERNEURON; MAJOR AFFECTIVE DISORDER; MALE; MOTOR DYSFUNCTION; PHENOTYPE; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; REDUCTION; STEREOLOGY; SYMPTOM ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; CELL COUNT; CEREBRAL CORTEX; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HUNTINGTON DISEASE; INTERNEURONS; MALE; MIDDLE AGED;

EID: 84902204015     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24162     Document Type: Article

References (44)

1. Georgiou N, Bradshaw JL, Chiu E, et al. Differential clinical and motor control function in a pair of monozygotic twins with Huntington's disease. Mov Disord 1999; 14: 320-325.
2. Friedman JH, Trieschmann ME, Myers RH, Fernandez HH,. Monozygotic twins discordant for Huntington disease after 7 years. Arch Neurol 2005; 62: 995-997.
3. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971-983.
4. Vonsattel JP, DiFiglia M,. Huntington disease. J Neuropathol Exp Neurol 1998; 57: 369-384.
5. Reiner A, Albin RL, Anderson KD, et al. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A 1988; 85: 5733-5737.
6. Hedreen JC, Peyser CE, Folstein SE, Ross CA,. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett 1991; 133: 257-261.
7. Sotrel A, Williams RS, Kaufmann WE, Myers RH,. Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease: a quantitative Golgi study. Neurology 1993; 43: 2088-2096.
8. Macdonald V, Halliday G,. Pyramidal cell loss in motor cortices in Huntington's disease. Neurobiol Dis 2002; 10: 378-386.
9. Tippett LJ, Waldvogel HJ, Thomas SJ, et al. Striosomes and mood dysfunction in Huntington's disease. Brain 2007; 130: 206-221.
10. Thu DC, Oorschot DE, Tippett LJ, et al. Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. Brain 2010; 133: 1094-1110.
11. Rosas HD, Hevelone ND, Zaleta AK, et al. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 2005; 65: 745-747.
12. Rosas HD, Salat DH, Lee SY, et al. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain 2008; 131: 1057-1068.
13. DeFelipe J, Farinas I,. The pyramidal neuron of the cerebral cortex: morphological and chemical characteristics of the synaptic inputs. Prog Neurobiol 1992; 39: 563-607.
14. DeFelipe J,. Cortical interneurons: from Cajal to 2001. Prog Brain Res 2002; 136: 215-238.
15. Markram H, Toledo-Rodriguez M, Wang Y, et al. Interneurons of the neocortical inhibitory system. Nat Rev Neurosci 2004; 5: 793-807.
16. Waldvogel HJ, Curtis MA, Baer K, et al. Immunohistochemical staining of post-mortem adult human brain sections. Nat Protoc 2006; 1: 2719-2732.
17. Seto-Ohshima A, Emson PC, Lawson E, et al. Loss of matrix calcium-binding protein-containing neurons in Huntington's disease. Lancet 1988; 1: 1252-1255.
18. West MJ, Slomianka L, Gundersen HJ,. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991; 231: 482-497.
19. West MJ, Gundersen HJ,. Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol 1990; 296: 1-22.
20. Lange HW,. Quantitative changes of telencephalon, diencephalon, and mesencephalon in Huntington's chorea, postencephalitic, and idiopathic parkinsonism. Verh Anat Ges 1981; 75: 923-925.
21. Zaitsev AV, Gonzalez-Burgos G, Povysheva NV, et al. Localization of calcium-binding proteins in physiologically and morphologically characterized interneurons of monkey dorsolateral prefrontal cortex. Cereb Cortex 2005; 15: 1178-1186.
22. Conde F, Lund JS, Jacobowitz DM, et al. Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: distribution and morphology. J Comp Neurol 1994; 341: 95-116.
23. Gabbott PL, Jays PR, Bacon SJ,. Calretinin neurons in human medial prefrontal cortex (areas 24a,b,c, 32, and 25). J Comp Neurol 1997; 381: 389-410.
24. Fonseca M, Soriano E,. Calretinin-immunoreactive neurons in the normal human temporal cortex and in Alzheimer's disease. Brain Res 1995; 691: 83-91.
25. del Rio MR, DeFelipe J,. Double bouquet cell axons in the human temporal neocortex: relationship to bundles of myelinated axons and colocalization of calretinin and calbindin D-28k immunoreactivities. J Chem Neuroanat 1997; 13: 243-251.
26. del Rio MR, DeFelipe J,. Colocalization of calbindin D-28k, calretinin, and GABA immunoreactivities in neurons of the human temporal cortex. J Comp Neurol 1996; 369: 472-482.
27. Demeulemeester H, Arckens L, Vandesande F, et al. Calcium binding proteins and neuropeptides as molecular markers of GABAergic interneurons in the cat visual cortex. Exp Brain Res 1991; 84: 538-544.
28. Carder RK, Leclerc SS, Hendry SH,. Regulation of calcium-binding protein immunoreactivity in GABA neurons of macaque primary visual cortex. Cereb Cortex 1996; 6: 271-287.
29. Myers RH, Sax DS, Koroshetz WJ, et al. Factors associated with slow progression in Huntington's disease. Arch Neurol 1991; 48: 800-804.
30. Zappacosta B, Monza D, Meoni C, et al. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease. Arch Neurol 1996; 53: 493-497.
31. Thompson JC, Snowden JS, Craufurd D, Neary D,. Behavior in Huntington's disease: dissociating cognition-based and mood-based changes. J Neuropsychiatry Clin Neurosci 2002; 14: 37-43.
32. Chouinard PA, Paus T,. The primary motor and premotor areas of the human cerebral cortex. Neuroscientist 2006; 12: 143-152.
33. Matelli M, Luppino G, Geyer S, Zilles K,. Motor cortex. In:, Paxinos G, Mai JK, eds. The Human Nervous System. 2nd ed. San Diego, CA: Academic Press, 2004: 973-996.
34. Devinsky O, Morrell MJ, Vogt BA,. Contributions of anterior cingulate cortex to behaviour. Brain 1995; 118: 279-306.
35. Paus T,. Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat Rev Neurosci 2001; 2: 417-424.
36. Vogt BA, Finch DM, Olson CR,. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex 1992; 2: 435-443.
37. Rajkowska G, O'Dwyer G, Teleki Z, et al. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 2007; 32: 471-482.
38. DeFelipe J,. Chandelier cells and epilepsy. Brain 1999; 122: 1807-1822.
39. Beasley CL, Zhang ZJ, Patten I, Reynolds GP,. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol Psychiatry 2002; 52: 708-715.
40. Benes FM, Berretta S,. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001; 25: 1-27.
41. Hashimoto T, Volk DW, Eggan SM, et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 2003; 23: 6315-6326.
42. Gu X, Li C, Wei W, et al. Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron 2005; 46: 433-444.
43. Spampanato J, Gu X, Yang XW, Mody I,. Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease. Neuroscience 2008; 157: 606-620.
44. Cummings DM, Andre VM, Uzgil BO, et al. Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease. J Neurosci 2009; 29: 10371-10386.